Literature DB >> 12439099

The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause.

Wulf H Utian1, Jeffrey W Janata, Sheryl A Kingsberg, Mark Schluchter, James C Hamilton.   

Abstract

OBJECTIVE: Quality of life (QOL) is an outcome variable requiring measurement in clinical care or pivotal regulatory trial research. Current menopause QOL measures are mostly life phase or disease symptom inventories or scores. Believing that QOL should refer more to "sense of well-being," we have developed the Utian QOL scale (UQOL) that is strongly based on perception of sense of well-being as distinct from menopausal symptoms.
DESIGN: A pool of items sampling various aspects of well-being was developed. Peri- and postmenopausal women (n = 327) responded to the items, and their responses were subjected to a factor analysis. Four factors emerged, each representing a QOL domain. The resulting 23-item instrument was validated in a geographically and socioeconomically diverse sample of peri- and postmenopausal women using the Short Form-36, an established, frequently used QOL inventory. QOL domains were subjected to confirmatory factor analyses, formal item analysis was completed, and the measure was assessed for reliability and validity, including a second sample of women (n = 270).
RESULTS: Women (n = 597; mean age, 52.9 years) from 12 communities across the United States completed the measure. The UQOL seems to reflect four components of QOL: occupational QOL, health QOL, emotional QOL, and sexual QOL. The questionnaire and scoring system are presented.
CONCLUSION: We are reporting on the process of validating an instrument for quantifying sense of well-being in a perimenopausal population. Substantial reliability and validity estimates for the scale and its subscales support the UQOL as a valuable new tool for use in clinical research and practice.

Entities:  

Mesh:

Year:  2002        PMID: 12439099     DOI: 10.1097/00042192-200211000-00005

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   3.310


  22 in total

1.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

2.  Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.

Authors:  Dahima Cintron; John P Beckman; Kent R Bailey; Brian D Lahr; Muthuvel Jayachandran; Virginia M Miller
Journal:  Maturitas       Date:  2017-02-17       Impact factor: 4.342

Review 3.  Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications.

Authors:  Sara E Dolan Looby
Journal:  J Assoc Nurses AIDS Care       Date:  2011-09-15       Impact factor: 1.354

Review 4.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

5.  Factors associated with sexual quality of life among midlife women in Serbia.

Authors:  Tatjana Gazibara; Selmina Nurkovic; Nikolina Kovacevic; Ilma Kurtagic; Biljana Rancic; Sanja Radovanovic; Branislav Milosevic; Milan Terzic; Jelena Dotlic
Journal:  Qual Life Res       Date:  2017-06-03       Impact factor: 4.147

Review 6.  Literature review of instruments to assess health-related quality of life during and after menopause.

Authors:  Y F Zöllner; C Acquadro; M Schaefer
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

7.  Tai Chi for osteopenic women: design and rationale of a pragmatic randomized controlled trial.

Authors:  Peter M Wayne; Julie E Buring; Roger B Davis; Ellen M Connors; Paolo Bonato; Benjamin Patritti; Mary Fischer; Gloria Y Yeh; Calvin J Cohen; Danette Carroll; Douglas P Kiel
Journal:  BMC Musculoskelet Disord       Date:  2010-03-01       Impact factor: 2.362

Review 8.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

9.  Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.

Authors:  David R Walega; Leah H Rubin; Suzanne Banuvar; Lee P Shulman; Pauline M Maki
Journal:  Menopause       Date:  2014-08       Impact factor: 2.953

10.  Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life.

Authors:  Kerry L Hildreth; Cemal Ozemek; Wendy M Kohrt; Patrick J Blatchford; Kerrie L Moreau
Journal:  Menopause       Date:  2018-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.